Moore Capital Management »

Pliant Therapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $489k 27k 18.12

More positions owned by Moore Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Bank of America Corporation (BAC)
Amazon (AMZN)
Freeport-mcmoran CL B Call Option (FCX)
Ally Financial (ALLY)
Aon Shs Cl A (AON)
Spotify Technology S A SHS (SPOT)
Netflix (NFLX)

View all positions for Moore Capital Management

Top funds holding Pliant Therapeutics

Tang Capital Management
Woodline Partners
Point72 Asset Management
Blue Owl Capital Holdings
Vanguard Group
Acadian Asset Management
Citadel Advisors
Jpmorgan Chase & Co
Redmile Group
BlackRock
UBS Group
Peapod Lane Capital
Two Sigma Advisers
Renaissance Technologies
Dr. Jeffrey R. Jay, M.D.

View all funds holding Pliant Therapeutics